Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion

Detalles Bibliográficos
Autores principales: Halford, Sarah, Wan, Susan, Dragoni, Ilaria, Silvester, Julie, Nazarov, Bobojon, Anthony, Daniel, Anthony, Suzie, Ladds, Emma, Norrie, John, Dhaliwal, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022056/
https://www.ncbi.nlm.nih.gov/pubmed/35449061
http://dx.doi.org/10.1186/s13063-022-06266-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022056/
https://www.ncbi.nlm.nih.gov/pubmed/35449061
http://dx.doi.org/10.1186/s13063-022-06266-0

Ejemplares similares